Abnormal DSTs occurred in both patients with primary degenerative dementia (n = 43, 34
, and the blood is drawn at 8 a
INTRODUCTION When evaluating a patient who has evidence of cognitive decline, a number of reversible causes need to be excluded before one can diagnose
The dexamethasone suppression test (DST) was developed from the neuroendocrine research strategy to provide indirect information about the integrity of the limbic system in
139
1982 Apr;139 (4):479-81
The dexamethasone suppression test (DST) was performed on 21 patients with dementia of the Alzheimer type (DAT), 11 patients with multiinfarct dementia (Ml) and 14 healthy
A dexamethasone suppression test is primarily used to help diagnose Cushing syndrome
F
The author describes 10 patients with pseudodementia and compares its clinical features with those of true dementia
The dexamethasone suppression test (DST) was performed on 13 patients with multi-infarct dementia (MID), 5 patients with primary degenerative dementia (PDD) and 18 elderly
Rudorfer, M
The low-dose dexamethasone suppression test is used to differentiate patients with hypercortisolism of any etiology from those with a normal HPA axis
479-481; bibl
They are the "low dose" and the "high dose" dexamethasone suppression tests
Carroll, B
The DST may be useful in diagnosing catatonia, geriatric depressive pseudodementia, melancholia, depression in adolescence or childhood, masked depression, complicated depression, and suicidal
See Full PDF Download PDF
Take the prescribed 1 mg dose of dexamethasone
Failure to suppress cortisol output will NOT diagnose Cushing's but cortisol supression will exclude the majority of patients thought to have the disease
The rationale for this research strategy was that
Studies presenting individual values for patients with CD and normal subjects were identified through PubMed searches and